113 4 Diabetes-tuberculosis comorbidity in a low-income setting Supplementary File 2: Multi-level model of individual risk factors of elevated blood glucose accounting for clustering of individuals within regions. Variable Univariate Multivariate Odds 95% CI P-Value Odds 95% CI P-Value Age 1.02 0.99, 1.05 0.111 Baseline HIV Status Non-Reactive 1 Reactive 3.01 0.89, 10.23 0.077 4.62 1.06, 20.1 0.042 Sex Female 1 Male 1.33 0.61, 2.93 0.476 Family history of DM No 1 Unknown 2.71 0.98, 7.47 0.055 2.81 0.99, 7.99 0.053 Yes 2.98 1.18, 7.51 0.021 2.80 1.08, 7.32 0.035 Duration of treatment 0.86 0.72, 1.02 0.093 Diastolic blood pressure 1.03 0.99, 1.07 0.085 1.02 0.99, 1.05 0.132 Baseline weight 0.98 0.96, 1.01 0.283 Education None 1 Primary 0.68 0.23, 1.99 0.477 High School 0.40 0.15, 1.05 0.064 Tertiary 0.39 0.08, 1.93 0.247 Random effects Standard Deviation = 3.46e-08; Prob >= chibar2 = 1.0000 Supplementary File 3: Tuberculosis Treatment Outcome disaggregated by sex Treatment outcome Female (N=167) Male (N=202) Total (N=369) Active 3 (1.8%) 3 (1.5%) 6 (1.6%) Completed 79 (47.3%) 71 (35.1%) 150 (40.7%) Cured 55 (32.9%) 71 (35.1%) 126 (34.1%) DRTB on Treatment 2 (1.2%) 1 (0.5%) 3 (0.8%) Died 14 (8.4%) 20 (9.9%) 34 (9.2%) LTFU 3 (1.8%) 16 (7.9%) 19 (5.1%) Not Evaluated 1 (0.6%) 0 (0.0%) 1 (0.3%) Re-initiation 1 (0.6%) 5 (2.5%) 6 (1.6%) Stopped 1 (0.6%) 1 (0.5%) 2 (0.5%) Transferred out 4 (2.4%) 9 (4.5%) 13 (3.5%) Treatment Failure 4 (2.4%) 5 (2.5%) 9 (2.4%)
RkJQdWJsaXNoZXIy MTk4NDMw